Mega Lifesciences PCL (BKK:MEGA)
29.50
-0.75 (-2.48%)
Apr 4, 2025, 4:37 PM ICT
Mega Lifesciences PCL Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 3,463 | 2,357 | 2,453 | 2,198 | 1,006 | Upgrade
|
Short-Term Investments | 395.19 | 365.05 | 345.55 | 342.64 | 225.85 | Upgrade
|
Cash & Short-Term Investments | 3,858 | 2,722 | 2,799 | 2,540 | 1,232 | Upgrade
|
Cash Growth | 41.74% | -2.76% | 10.18% | 106.14% | -16.02% | Upgrade
|
Accounts Receivable | 2,975 | 3,314 | 3,107 | 2,557 | 2,507 | Upgrade
|
Other Receivables | 152.53 | 158.28 | 180.15 | 164.18 | 74.68 | Upgrade
|
Receivables | 3,128 | 3,472 | 3,287 | 2,721 | 2,581 | Upgrade
|
Inventory | 3,033 | 3,377 | 4,109 | 3,823 | 3,489 | Upgrade
|
Prepaid Expenses | 60.43 | 58.59 | 60.14 | 53.43 | 43.95 | Upgrade
|
Other Current Assets | 147.7 | 360.23 | 334.95 | 162.8 | 240.19 | Upgrade
|
Total Current Assets | 10,227 | 9,990 | 10,590 | 9,301 | 7,587 | Upgrade
|
Property, Plant & Equipment | 2,213 | 2,225 | 2,151 | 2,103 | 2,214 | Upgrade
|
Long-Term Investments | 40.39 | 221.15 | 222.88 | 214.79 | 194.47 | Upgrade
|
Goodwill | 449 | 456.24 | 465.88 | 476.25 | 437.32 | Upgrade
|
Other Intangible Assets | 869.72 | 862.23 | 863.31 | 876.89 | 875 | Upgrade
|
Long-Term Deferred Tax Assets | 299.89 | 278.95 | 250.32 | 210.41 | 175.03 | Upgrade
|
Other Long-Term Assets | 111.52 | 81 | 103.49 | 89.75 | 74.27 | Upgrade
|
Total Assets | 14,210 | 14,115 | 14,646 | 13,272 | 11,557 | Upgrade
|
Accounts Payable | 1,685 | 1,925 | 2,793 | 2,527 | 2,048 | Upgrade
|
Accrued Expenses | 1,102 | 1,140 | 1,604 | 1,283 | 823.52 | Upgrade
|
Short-Term Debt | 287.58 | 76 | 229.18 | 168.18 | 499.49 | Upgrade
|
Current Portion of Leases | 63.83 | 43.78 | 82.96 | 56.21 | 36.67 | Upgrade
|
Current Income Taxes Payable | 145.54 | 108.45 | 204.18 | 185.86 | 160.73 | Upgrade
|
Other Current Liabilities | 630.65 | 1,133 | 624.44 | 633.02 | 660.61 | Upgrade
|
Total Current Liabilities | 3,914 | 4,427 | 5,538 | 4,853 | 4,229 | Upgrade
|
Long-Term Leases | 139.83 | 132.06 | 108.73 | 131.94 | 111.31 | Upgrade
|
Long-Term Deferred Tax Liabilities | 1.05 | 2.14 | - | - | 0.98 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 0.33 | Upgrade
|
Total Liabilities | 4,333 | 4,813 | 5,870 | 5,247 | 4,578 | Upgrade
|
Common Stock | 435.94 | 435.94 | 435.94 | 435.94 | 435.94 | Upgrade
|
Additional Paid-In Capital | 2,305 | 2,305 | 2,305 | 2,305 | 2,305 | Upgrade
|
Retained Earnings | 7,830 | 7,210 | 6,655 | 5,766 | 4,752 | Upgrade
|
Comprehensive Income & Other | -693.31 | -648.11 | -618.9 | -503.97 | -534.41 | Upgrade
|
Total Common Equity | 9,877 | 9,302 | 8,777 | 8,003 | 6,958 | Upgrade
|
Minority Interest | 0.08 | 0.02 | 0.07 | 22.3 | 21.29 | Upgrade
|
Shareholders' Equity | 9,877 | 9,302 | 8,777 | 8,025 | 6,979 | Upgrade
|
Total Liabilities & Equity | 14,210 | 14,115 | 14,646 | 13,272 | 11,557 | Upgrade
|
Total Debt | 491.24 | 251.84 | 420.87 | 356.33 | 647.47 | Upgrade
|
Net Cash (Debt) | 3,367 | 2,470 | 2,378 | 2,184 | 584.84 | Upgrade
|
Net Cash Growth | 36.31% | 3.86% | 8.89% | 273.44% | 1.37% | Upgrade
|
Net Cash Per Share | 3.86 | 2.83 | 2.73 | 2.50 | 0.67 | Upgrade
|
Filing Date Shares Outstanding | 871.87 | 871.87 | 871.87 | 871.87 | 871.87 | Upgrade
|
Total Common Shares Outstanding | 871.87 | 871.87 | 871.87 | 871.87 | 871.87 | Upgrade
|
Working Capital | 6,312 | 5,563 | 5,052 | 4,448 | 3,358 | Upgrade
|
Book Value Per Share | 11.33 | 10.67 | 10.07 | 9.18 | 7.98 | Upgrade
|
Tangible Book Value | 8,558 | 7,984 | 7,447 | 6,650 | 5,645 | Upgrade
|
Tangible Book Value Per Share | 9.82 | 9.16 | 8.54 | 7.63 | 6.47 | Upgrade
|
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.